Wednesday, February 10, 2010, 3:53am EST - Canadian Markets open in 5 hours and 37 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Jennison Health Sciences C (PHLCX)

On Feb 9: 17.67 USD  Up 0.13 (0.74%)  
MORE ON PHLCX
Quotes
Charts
News & Info
Fund
HereProfile
Analyst

Profile  As of 31-Dec-07 Get Profile for:
Jennison Health Sciences C
Gateway Center Three, 4th Floor 100 Mulberry Street Newark NJ 07102
Phone: 800-225-1852
Free prospectuses for
more than 1,000 funds!
View List of Free Prospectuses
FUND OVERVIEW
Category: Specialty-Health
Fund Family: JennisonDryden
Net Assets: 123.79M
Year-to-Date Return: 16.16%
Yield: 0.00%
Morningstar Rating: 5 stars
Fund Inception Date: 30-Jun-99
MORNINGSTAR STYLE BOX
Specialty-Health
[View Category Definition]
View Top Specialty-Health Funds
About the Morningstar Style Box
MANAGEMENT INFORMATION
David Chan
Lead Manager since 30-Jun-99
Chan joined Jennison Associates in 1992 and is a director and senior vice president. Previously, he was employed at Boston Consulting Group where he was a team leader and consultant on projects in many industries, including pharmaceuticals and drug retailing and distribution. Chan holds the Chartered Financial Analyst designation.
INVESTMENT INFORMATION
Min Initial Investment: $2,500
Min Initial Investment, IRA: $0
Min Initial Investment, AIP: $50
Min Subsequent Investment: $100
Min Subsequent Investment, IRA: $0
Min Subsequent Investment, AIP: $50
PHLCX can be purchased from 38 brokerages.
FUND SUMMARY
The investment seeks long-term capital appreciation. The fund normally invests at least 80% of investable assets in equity and equity-related securities of companies in the banking and financial services group of industries. It may invest more than 5% of assets in any one issuer. The fund may invest in ADRs and S&P Depositary Receipts, REITs, warrants and rights. It may participate in the IPO market. The fund may also invest up to 35% of total assets in foreign securities (excluding ADRs, ADSs, or similar receipts and shares traded in U.S. markets). It is nondiversified.
FUND OPERATIONS
Last Dividend (27-Nov-06): 0.00
Last Cap Gain (12-Dec-07): 2.12
Annual Holdings Turnover 103.00%
Average for Category: 111.27%
FEES & EXPENSES
Expense PHLCX Category
Avg
Total Expense Ratio: 1.94% 1.71%
Max 12b1 Fee: 1.00% N/A
Max Front End Sales Load: 0.00% 5.29%
Max Deferred Sales Load: 1.00% 2.95%
3 Yr Expense Projection*: $609 $723
5 Yr Expense Projection*: $1,047 $1,095
10 Yr Expense Projection*: $2,264 $2,134
* Per $10,000 invested


Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Profile for Another Symbol:
Symbol Lookup
Latest News Canadian Indices